查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828163

2025年全球肾臟去神经支配设备市场报告

Renal Denervation Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，肾臟去神经支配器材市场快速扩张，市场规模从2024年的5.5亿美元成长至2025年的7.4亿美元，复合年增长率达33.1%。预测期内的成长归因于高血压病例数量的增加、临床研究的开展、心血管疾病的增加、FDA的首批核准和监管发展，以及肾臟去神经支配系统的市场发展。

预计未来几年肾臟去神经支配器材市场规模将呈指数级增长，到2029年将达到22.7亿美元，复合年增长率为32.5%。预测期内的成长可归因于以病人为中心的理念、医疗基础设施的建设、认知度和接受度的提升、对微创治疗的重视以及新型器械的上市。预测期内的主要趋势包括人工智慧 (AI) 与机器学习的融合、监管格局的变化、向微创治疗的转变、对临床证据的日益重视、远端监控以及远端医疗的整合。

肾臟去神经支配装置是一种微创医疗解决方案，旨在治疗对常规干预措施无效的顽固性高血压。这类装置需将导管插入肾动脉，并利用射频能源消融血管壁内的交感神经。这一过程可以增强肾臟的血流。

肾臟去神经支配器材市场的主要产品包括Simplicity肾臟去神经支配系统、EnligHTN、Vessix肾臟去神经支配系统、Iberis肾臟交感神经去神经支配系统和Paradise肾臟去神经支配系统。例如，Simplicity肾臟去神经支配系统利用导管和发生器将射频能源输送至肾神经。这些器械采用多种技术，包括射频消融术、基于超音波能量的肾臟去神经支配(RDN)、近距离放射治疗和化学消融。目标终端使用者包括医院、心血管研究机构和其他医疗机构。

2025年，美国关税的大幅上调及其引发的贸易摩擦将对医疗设备产业产生重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品的影响。由于医院和诊所抵制价格上涨，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供肾去神经装置光学元件市场统计数据，包括全球市场规模、区域份额、肾去神经装置光学元件市场份额的竞争对手、详细的肾去神经装置光学元件细分市场、市场趋势和商机，以及在肾去神经装置光学元件行业取得成功所需的数据。本肾去神经装置光学元件市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为32.5%，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这将对美国产生直接影响，因为美国主要从荷兰和爱尔兰进口的射频消融术导管和神经标测电极的关税将提高，这可能会增加高血压治疗的成本。此外，由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛。

预计未来几年，高血压盛行率的上升将推动肾去神经支配器械市场的扩张。高血压，俗称血压升高，是指血液对血管壁的压力持续升高而导致的。肾去神经支配术是一种基于导管的治疗方法，已成为难治性高血压患者一种相当前景的治疗方法。这种微创的、临床实验的治疗方法旨在治疗对标准药物治疗无效的高血压。例如，美国政府机构疾病管制与预防中心于2024年5月报告称，高血压在2022年导致或直接导致了美国685,875人死亡。因此，预计高血压盛行率的上升将推动肾去神经支配器械市场的成长。

预计肾臟去神经支配器材市场的成长将受到医疗保健支出成长的推动。医疗保健支出包括与提供医疗保健服务相关的所有费用，例如计划生育援助、营养计划和紧急医疗援助。不断增长的医疗保健支出透过为患者和医疗保健系统提供资金支持，在促进肾臟去神经支配器械的普及方面发挥关键作用。例如，2023 年 6 月，美国医疗保险和医疗补助服务中心报告称，到 2021 年，美国的医疗保健支出将增长 2.7%，达到 4.3 兆美元，即人均 12,914 美元，占国内生产总值的 18.3%。医疗保健支出的这种上升趋势进一步支撑了肾臟去神经支配器材市场的成长轨迹。

肾臟去神经支配设备市场的主要企业正专注于开发超音波肾臟去神经支配 (uRDN)，以改善治疗结果、最大限度地减少手术併发症，并提供传统肾臟去神经支配方法的非侵入性替代方案。 uRDN 透过促进精确、非侵入性的能量输送到肾臟神经来增强肾臟去神经支配设备，有效降低血压同时保护周围组织，从而提高患者在手术过程中的安全性和舒适度。例如，2023 年 11 月，美国医疗技术公司 Recor Medical Inc. 推出了 Paradise uRDN 系统，这是一款创新的超音波肾臟去神经支配设备，用于治疗无法透过标准生活方式改变和药物达到血压目标的高血压患者。该系统结合水冷技术，在手术过程中保护肾动脉，为管理难治性高血压提供了一种新的非药物方法，并扩大了患者的治疗选择，标誌着肾臟去神经支配设备市场的重大进步。

肾臟去神经支配器材市场的公司越来越重视引入微创治疗方案，以增强其竞争地位。 2023年11月，美国医疗设备製造商Recor Medical在美国推出了Paradise超音波肾臟去神经支配疗法。这是美国首个获得FDA核准的肾臟去神经支配疗法，利用超音波技术去除肾动脉周围的交感神经，从而缓解高血压引起的过度兴奋。 Paradise系统在临床试验中显示出显着的降血压效果，标誌着高血压管理领域的重要进展。

2022年4月，英国综合受託研究机构Clinical Accelerator与Verve Medical合作，针对一款专为难治性高血压患者设计的创新医疗设备进行人体初步可行性研究。 Verve Medical是一家美国医疗设备製造商，在开发突破性解决方案以应对高血压相关挑战方面处于领先地位，进一步彰显了该行业对持续创新的承诺。

肾臟去神经支配设备市场的主要企业包括美敦力公司 (Medtronic PLC)、ReCor Medical Inc.、波士顿科学公司 (Boston Scientific Corporation)、雅培实验室 (Abbott Laboratories)、Cordis 公司、Terumo 公司、Kona Medical Inc.、St. Jude Medical LLC、强生公司 (Johnson & Medion InccatorS. Inc.、Cardiosonic Ltd.、Renal Dynamics Ltd.、Vesalio LLC、Atricure Inc.、Biosense Webster Inc.、Biotronik SE & Co. KG、Cook Medical LLC、Hansen Medical Inc.、Merit Medical Systems Inc.、AngioDynamics Inc.、Covidien Ltd.、Volcano 公司、Edwards Inc.、AngioDynamics Inc.、Covidien Ltd.、Volcano 公司、Edwards商人Ltd.、Oscor Inc. 和 Balton Sp. z oo。

2024年，欧洲是肾臟去神经支配器材市场最大的地区。根据全球肾臟去神经支配器材市场报告，预计亚太地区将成为预测期内成长最快的地区。肾臟去神经支配器材市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

肾臟去神经支配装置市场报告涉及的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙。

肾臟去神经支配器材市场涵盖单电极、多电极、灌注导管等产品的销售。该市场的价值指的是“出厂价”，即产品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肾臟去神经支配装置：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球肾臟去神经支配设备市场：成长率分析
  • 全球肾臟去神经支配装置市场表现：规模与成长，2019-2024
  • 全球肾臟去神经支配装置市场预测：规模与成长，2024-2029，2034
  • 全球肾臟去神经支配装置：总目标市场（TAM）

第六章 市场细分

  • 全球肾臟去神经支配设备市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 简易肾臟去神经支配系统
  • EnligHTN
  • Vessix 肾臟去神经支配系统
  • Iberis 肾交感神经去神经支配系统
  • 天堂肾臟去神经系统
  • 其他产品
  • 全球肾臟去神经支配设备市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 射频消融术
  • 基于超音波能量的RDN
  • 近距离放射治疗
  • 科学消融
  • 其他的
  • 全球肾臟去神经支配设备市场（依最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 心血管研究所
  • 其他的
  • 全球肾臟去神经支配设备市场：简易肾臟去神经支配系统细分市场，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 导管系统
  • 配件
  • 全球肾臟去神经支配设备市场：EnligHTN 细分市场、类型、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • 导管系统
  • 发电机
  • 配件
  • 全球肾臟去神经支配设备市场：Vessix 肾臟去神经支配系统细分市场、类型、表现及预测（2019-2024 年、2024-2029 年、2034 年）
  • 球囊导管
  • 发电机
  • 配件
  • 全球肾臟去神经支配设备市场：Iberis 肾臟交感神经去神经支配系统细分市场、按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 导管系统
  • 配件
  • 全球肾臟去神经支配设备市场：天堂肾臟去神经支配系统细分市场，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 导管系统
  • 配件
  • 全球肾臟去神经支配设备市场：其他细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 新兴技术
  • 替代设备

第七章 区域和国家分析

  • 全球肾臟去神经支配设备市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球肾臟去神经支配设备市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 肾臟去神经支配装置市场：竞争格局
  • 肾臟去神经支配设备市场：公司简介
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • ReCor Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Cordis Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Terumo Corporation
  • Kona Medical Inc.
  • St. Jude Medical LLC
  • Johnson & Johnson
  • Mercator MedSystems Inc.
  • Symple Surgical Inc.
  • Ablative Solutions Inc.
  • Cardiosonic Ltd.
  • Renal Dynamics Ltd.
  • Vesalio LLC
  • Atricure Inc.
  • Biosense Webster Inc.
  • Biotronik SE & Co. KG
  • Cook Medical LLC
  • Hansen Medical Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年肾臟去神经支配设备市场：提供新机会的国家
  • 2029年肾臟去神经支配设备市场：细分市场带来新机会
  • 肾臟去神经支配设备市场 2029 年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24451u

Renal denervation devices represent minimally invasive medical solutions designed for the treatment of resistant hypertension cases unresponsive to conventional interventions. These devices involve the insertion of a catheter into the renal arteries, employing radiofrequency energy to ablate sympathetic nerves within the vessel walls. This process enhances blood flow to the kidneys.

Key products in the renal denervation devices market include the Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, and others. The Simplicity Renal Denervation System, for instance, utilizes a catheter and generator to deliver radiofrequency energy to the renal nerves. Various technologies, such as radiofrequency ablation, ultrasound energy-based RDN, brachytherapy, chemical ablation, and others, are employed by these devices. Target end-users include hospitals, cardiovascular research centers, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The renal denervation devices market research report is one of a series of new reports from The Business Research Company that provides renal denervation devices optical components market statistics, including renal denervation devices optical components industry global market size, regional shares, competitors with a renal denervation devices optical components market share, detailed renal denervation devices optical components market segments, market trends and opportunities, and any further data you may need to thrive in the renal denervation devices optical components industry. This renal denervation devices optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The renal denervation devices market size has grown exponentially in recent years. It will grow from $0.55 billion in 2024 to $0.74 billion in 2025 at a compound annual growth rate (CAGR) of 33.1%. The growth in the historic period can be attributed to increased hypertension cases, clinical research and studies, increased in cardiovascular diseases, initial FDA approval and regulatory developments, market entry of renal denervation systems.

The renal denervation devices market size is expected to see exponential growth in the next few years. It will grow to $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 32.5%. The growth in the forecast period can be attributed to patient-centric approach, healthcare infrastructure development, growing awareness and acceptance, focus on minimally invasive therapies, market entry of new devices. Major trends in the forecast period include integration of artificial intelligence (ai) and machine learning, regulatory landscape changes, shift towards minimally invasive procedures, emphasis on clinical evidence, remote monitoring and telehealth integration.

The forecast of 32.5% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased tariffs on radiofrequency ablation catheters and nerve mapping electrodes, mainly imported from the Netherlands and Ireland, raising costs for hypertension treatment.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of hypertension is projected to stimulate the expansion of the renal denervation devices market in the coming years. Hypertension, commonly referred to as high blood pressure, occurs when the force of blood against the walls of the blood vessels remains consistently elevated. Renal denervation is a catheter-based procedure that has emerged as a promising treatment option for patients with resistant hypertension. This minimally invasive, investigational technique is designed to address hypertension that has not responded to standard medications. For instance, in May 2024, the Centers for Disease Control and Prevention, a US government agency, reported that high blood pressure was a contributing factor in or directly caused 685,875 deaths in the United States in 2022. Thus, the increasing prevalence of hypertension is expected to drive growth in the renal denervation devices market.

The growth of the renal denervation devices market is expected to be propelled by the rise in healthcare expenditures. Healthcare expenditures encompass all costs associated with providing health services, including support for family planning, nutrition programs, and emergency health assistance. Increased healthcare spending plays a pivotal role in fostering the adoption of renal denervation devices by providing financial support for both patients and healthcare systems. As an example, in June 2023, the Centers for Medicare & Medicaid Services reported a 2.7% increase in healthcare expenditure in the United States, totaling $4.3 trillion or $12,914 per person in 2021, constituting 18.3% of the nation's gross domestic product. This upward trend in healthcare spending further supports the growth trajectory of the renal denervation devices market.

Leading companies in the renal denervation devices market are concentrating on the development of ultrasound renal denervation (uRDN) to improve treatment effectiveness, minimize procedural complications, and offer a non-invasive alternative to conventional renal denervation methods. uRDN enhances renal denervation devices by facilitating precise, non-invasive energy delivery to the renal nerves, which effectively reduces blood pressure while safeguarding surrounding tissues, thereby increasing patient safety and comfort during the procedure. For example, in November 2023, Recor Medical Inc., a US-based medical technology firm, introduced the Paradise uRDN system, an innovative ultrasound renal denervation device aimed at treating hypertension in patients who have not reached blood pressure targets through standard lifestyle modifications and medications. This system incorporates hydrocooling technology to protect the renal artery during the procedure, marking a significant advancement in the renal denervation devices market by providing a novel, non-pharmacologic method for managing resistant hypertension and broadening treatment options for patients.

Companies operating in the renal denervation devices market are increasingly emphasizing the introduction of minimally invasive options to strengthen their competitive position. In November 2023, Recor Medical, another US-based medical device company, launched the Paradise Ultrasound Renal Denervation Therapy in the United States. This marked the first FDA-approved renal denervation therapy in the country, utilizing ultrasound technology to denervate sympathetic nerves surrounding the renal arteries and mitigating overactivity that can contribute to hypertension. The Paradise System has exhibited significant blood pressure reductions in clinical trials, representing a crucial advancement in hypertension management.

In April 2022, Clinical Accelerator, a UK-based full-service contract research organization, collaborated with Verve Medical to conduct a preliminary human feasibility study on an innovative medical device designed for individuals facing treatment-resistant hypertension. Verve Medical Inc., a US-based medical equipment manufacturer, is at the forefront of developing groundbreaking solutions to address the challenges associated with hypertension, further underscoring the industry's commitment to continuous innovation.

Major companies operating in the renal denervation devices market include Medtronic PLC, ReCor Medical Inc., Boston Scientific Corporation, Abbott Laboratories, Cordis Corporation, Terumo Corporation, Kona Medical Inc., St. Jude Medical LLC, Johnson & Johnson, Mercator MedSystems Inc., Symple Surgical Inc., Ablative Solutions Inc., Cardiosonic Ltd., Renal Dynamics Ltd., Vesalio LLC, Atricure Inc., Biosense Webster Inc., Biotronik SE & Co. KG, Cook Medical LLC, Hansen Medical Inc., Merit Medical Systems Inc., AngioDynamics Inc., Covidien Ltd., Volcano Corporation, Edwards Lifesciences Corporation, InnoVein Inc., Teleflex Incorporated, Medinol Ltd., Oscor Inc., Balton Sp. z o.o.

Europe was the largest region in the renal denervation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the renal denervation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The renal denervation devices market consists of sales of products including a single electrode, multi-electrode, irrigated catheter, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Renal Denervation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on renal denervation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for renal denervation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The renal denervation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Simplicity Renal Denervation System; EnligHTN; Vessix Renal Denervation System; Iberis Renal Sympathetic Denervation System; Paradise Renal Denervation System; Other Products
  • 2) By Technology: Radio Frequency Ablation; Ultrasound Energy-Based RDN; Brachytherapy; Chemical Ablation; Other Technologies
  • 3) By End-Users: Hospitals; Cardiovascular research centre; Other End-Users
  • Subsegments:
  • 1) By Simplicity Renal Denervation System: Catheter System; Accessories
  • 2) By EnligHTN: Catheter System; Generator; Accessories
  • 3) By Vessix Renal Denervation System: Balloon Catheter; Generator; Accessories
  • 4) By Iberis Renal Sympathetic Denervation System: Catheter System; Accessories
  • 5) By Paradise Renal Denervation System: Catheter System; Accessories
  • 6) By Other Products: Emerging Technologies; Alternative Devices
  • Companies Mentioned: Medtronic PLC; ReCor Medical Inc.; Boston Scientific Corporation; Abbott Laboratories; Cordis Corporation; Terumo Corporation; Kona Medical Inc.; St. Jude Medical LLC; Johnson & Johnson; Mercator MedSystems Inc.; Symple Surgical Inc.; Ablative Solutions Inc.; Cardiosonic Ltd.; Renal Dynamics Ltd.; Vesalio LLC; Atricure Inc.; Biosense Webster Inc.; Biotronik SE & Co. KG; Cook Medical LLC; Hansen Medical Inc.; Merit Medical Systems Inc.; AngioDynamics Inc.; Covidien Ltd.; Volcano Corporation; Edwards Lifesciences Corporation; InnoVein Inc.; Teleflex Incorporated; Medinol Ltd.; Oscor Inc.; Balton Sp. z o.o.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Renal Denervation Devices Market Characteristics

3. Renal Denervation Devices Market Trends And Strategies

4. Renal Denervation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Renal Denervation Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Renal Denervation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Renal Denervation Devices Market Growth Rate Analysis
  • 5.4. Global Renal Denervation Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Renal Denervation Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Renal Denervation Devices Total Addressable Market (TAM)

6. Renal Denervation Devices Market Segmentation

  • 6.1. Global Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Simplicity Renal Denervation System
  • EnligHTN
  • Vessix Renal Denervation System
  • Iberis Renal Sympathetic Denervation System
  • Paradise Renal Denervation System
  • Other Products
  • 6.2. Global Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radio Frequency Ablation
  • Ultrasound Energy-Based RDN
  • Brachytherapy
  • Chemical Ablation
  • Other Technologies
  • 6.3. Global Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cardiovascular research centre
  • Other End-Users
  • 6.4. Global Renal Denervation Devices Market, Sub-Segmentation Of Simplicity Renal Denervation System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheter System
  • Accessories
  • 6.5. Global Renal Denervation Devices Market, Sub-Segmentation Of EnligHTN, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheter System
  • Generator
  • Accessories
  • 6.6. Global Renal Denervation Devices Market, Sub-Segmentation Of Vessix Renal Denervation System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Catheter
  • Generator
  • Accessories
  • 6.7. Global Renal Denervation Devices Market, Sub-Segmentation Of Iberis Renal Sympathetic Denervation System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheter System
  • Accessories
  • 6.8. Global Renal Denervation Devices Market, Sub-Segmentation Of Paradise Renal Denervation System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheter System
  • Accessories
  • 6.9. Global Renal Denervation Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Emerging Technologies
  • Alternative Devices

7. Renal Denervation Devices Market Regional And Country Analysis

  • 7.1. Global Renal Denervation Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Renal Denervation Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Renal Denervation Devices Market

  • 8.1. Asia-Pacific Renal Denervation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Renal Denervation Devices Market

  • 9.1. China Renal Denervation Devices Market Overview
  • 9.2. China Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Renal Denervation Devices Market

  • 10.1. India Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Renal Denervation Devices Market

  • 11.1. Japan Renal Denervation Devices Market Overview
  • 11.2. Japan Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Renal Denervation Devices Market

  • 12.1. Australia Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Renal Denervation Devices Market

  • 13.1. Indonesia Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Renal Denervation Devices Market

  • 14.1. South Korea Renal Denervation Devices Market Overview
  • 14.2. South Korea Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Renal Denervation Devices Market

  • 15.1. Western Europe Renal Denervation Devices Market Overview
  • 15.2. Western Europe Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Renal Denervation Devices Market

  • 16.1. UK Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Renal Denervation Devices Market

  • 17.1. Germany Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Renal Denervation Devices Market

  • 18.1. France Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Renal Denervation Devices Market

  • 19.1. Italy Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Renal Denervation Devices Market

  • 20.1. Spain Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Renal Denervation Devices Market

  • 21.1. Eastern Europe Renal Denervation Devices Market Overview
  • 21.2. Eastern Europe Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Renal Denervation Devices Market

  • 22.1. Russia Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Renal Denervation Devices Market

  • 23.1. North America Renal Denervation Devices Market Overview
  • 23.2. North America Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Renal Denervation Devices Market

  • 24.1. USA Renal Denervation Devices Market Overview
  • 24.2. USA Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Renal Denervation Devices Market

  • 25.1. Canada Renal Denervation Devices Market Overview
  • 25.2. Canada Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Renal Denervation Devices Market

  • 26.1. South America Renal Denervation Devices Market Overview
  • 26.2. South America Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Renal Denervation Devices Market

  • 27.1. Brazil Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Renal Denervation Devices Market

  • 28.1. Middle East Renal Denervation Devices Market Overview
  • 28.2. Middle East Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Renal Denervation Devices Market

  • 29.1. Africa Renal Denervation Devices Market Overview
  • 29.2. Africa Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Renal Denervation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Renal Denervation Devices Market Competitive Landscape
  • 30.2. Renal Denervation Devices Market Company Profiles
    • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. ReCor Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Cordis Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Renal Denervation Devices Market Other Major And Innovative Companies

  • 31.1. Terumo Corporation
  • 31.2. Kona Medical Inc.
  • 31.3. St. Jude Medical LLC
  • 31.4. Johnson & Johnson
  • 31.5. Mercator MedSystems Inc.
  • 31.6. Symple Surgical Inc.
  • 31.7. Ablative Solutions Inc.
  • 31.8. Cardiosonic Ltd.
  • 31.9. Renal Dynamics Ltd.
  • 31.10. Vesalio LLC
  • 31.11. Atricure Inc.
  • 31.12. Biosense Webster Inc.
  • 31.13. Biotronik SE & Co. KG
  • 31.14. Cook Medical LLC
  • 31.15. Hansen Medical Inc.

32. Global Renal Denervation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Renal Denervation Devices Market

34. Recent Developments In The Renal Denervation Devices Market

35. Renal Denervation Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Renal Denervation Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Renal Denervation Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Renal Denervation Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer